SZSE:301211 (China)
Â
Class A
Â¥
16.95
(+0.71%)
Apr 26
Business Description
Hubei Biocause Heilen Pharmaceutical Co Ltd
ISIN : CNE100005782
Share Class Description:
SZSE:301211: Class ACompare
Compare
Traded in other countries / regions
301211.China IPO Date
2021-12-22Description
Hubei Biocause Heilen Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and preparation products.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 267.37 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-EBITDA | 0.03 | |||||
| Interest Coverage | 1.79 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 18.75 | |||||
| Beneish M-Score | -2.46 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -16.7 | |||||
| 3-Year EBITDA Growth Rate | -21.8 | |||||
| 3-Year EPS without NRI Growth Rate | -3.1 | |||||
| 3-Year FCF Growth Rate | -27.5 | |||||
| 3-Year Book Growth Rate | 51.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 61.98 | |||||
| 9-Day RSI | 50.23 | |||||
| 14-Day RSI | 46.97 | |||||
| 6-1 Month Momentum % | -15.96 | |||||
| 12-1 Month Momentum % | -31.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 13.26 | |||||
| Quick Ratio | 12.42 | |||||
| Cash Ratio | 11.6 | |||||
| Days Inventory | 97.18 | |||||
| Days Sales Outstanding | 39.29 | |||||
| Days Payable | 57.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.36 | |||||
| Dividend Payout Ratio | 0.6 | |||||
| Forward Dividend Yield % | 2.36 | |||||
| 5-Year Yield-on-Cost % | 2.38 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 2.38 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.62 | |||||
| Operating Margin % | 24.42 | |||||
| Net Margin % | 26.93 | |||||
| FCF Margin % | 7.41 | |||||
| ROE % | 8.38 | |||||
| ROA % | 7.8 | |||||
| ROIC % | 33.11 | |||||
| ROC (Joel Greenblatt) % | 102.96 | |||||
| ROCE % | 12.06 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.49 | |||||
| PE Ratio without NRI | 25.3 | |||||
| PEG Ratio | 1.85 | |||||
| PS Ratio | 6.86 | |||||
| PB Ratio | 2.09 | |||||
| Price-to-Tangible-Book | 2.16 | |||||
| Price-to-Free-Cash-Flow | 94.94 | |||||
| Price-to-Operating-Cash-Flow | 23.44 | |||||
| EV-to-EBIT | 10.81 | |||||
| EV-to-EBITDA | 10.81 | |||||
| EV-to-Revenue | 4.21 | |||||
| EV-to-FCF | 56.88 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.96 | |||||
| Price-to-Graham-Number | 1.56 | |||||
| Price-to-Net-Current-Asset-Value | 2.51 | |||||
| Price-to-Net-Cash | 2.9 | |||||
| Earnings Yield (Greenblatt) % | 9.25 | |||||
| FCF Yield % | 1.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hubei Biocause Heilen Pharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 711.701 | ||
| EPS (TTM) (Â¥) | 0.663 | ||
| Beta | 0 | ||
| Volatility % | 33.28 | ||
| 14-Day RSI | 46.97 | ||
| 14-Day ATR (Â¥) | 0.572604 | ||
| 20-Day SMA (Â¥) | 17.07 | ||
| 12-1 Month Momentum % | -31.52 | ||
| 52-Week Range (Â¥) | 14.05 - 31.558333 | ||
| Shares Outstanding (Mil) | 288 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hubei Biocause Heilen Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hubei Biocause Heilen Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hubei Biocause Heilen Pharmaceutical Co Ltd Frequently Asked Questions
What is Hubei Biocause Heilen Pharmaceutical Co Ltd(SZSE:301211)'s stock price today?
The current price of SZSE:301211 is ¥16.95. The 52 week high of SZSE:301211 is ¥31.56 and 52 week low is ¥14.05.
When is next earnings date of Hubei Biocause Heilen Pharmaceutical Co Ltd(SZSE:301211)?
The next earnings date of Hubei Biocause Heilen Pharmaceutical Co Ltd(SZSE:301211) is .
Does Hubei Biocause Heilen Pharmaceutical Co Ltd(SZSE:301211) pay dividends? If so, how much?
The Dividend Yield %  of Hubei Biocause Heilen Pharmaceutical Co Ltd(SZSE:301211) is 2.36% (As of Today), Highest Dividend Payout Ratio of Hubei Biocause Heilen Pharmaceutical Co Ltd(SZSE:301211) was 0.6. The lowest was 0.6. And the median was 0.6. The  Forward Dividend Yield % of Hubei Biocause Heilen Pharmaceutical Co Ltd(SZSE:301211) is 2.36%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers